WeVote

Bill

Bill

HB 4907

REPEAL REYES SYN REPORTING ACT

103rd Regular Session Introduced by Omar Aquino and 2 co-sponsors

Illinois bill repealing synthetic drug reporting requirements, potentially limiting law enforcement monitoring of emerging drug trends and public health responses.

Senate Floor Amendment No. 2 Motion to Concur Rules Referred to Human Services Committee
0
WeVote Research Nonpartisan
Bill Summary · HB 4907

Legislative bill overview

HB 4907 seeks to repeal the Reyes Synthetic Drug Reporting Act in Illinois. The bill would eliminate state-mandated reporting requirements for synthetic drug sales and related transactions that were established under the previous legislation.

Why is this important

The Reyes Act created regulatory oversight mechanisms for synthetic drugs (often called "designer drugs" or "legal highs"). Repealing it would remove these reporting requirements, potentially affecting law enforcement's ability to track emerging synthetic drug trends and respond to public health threats related to these substances.

Potential points of contention

  • Public health impact: Removing reporting requirements could hinder efforts to monitor and respond to emerging synthetic drug threats and abuse patterns
  • Law enforcement coordination: Police and health agencies may lose valuable data infrastructure for identifying problematic synthetic substances before they become widespread
  • Implementation approach: The bill shows multiple amendments in motion, suggesting ongoing negotiation about scope or whether to fully repeal versus modify the existing act

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.